Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2020

Open Access 01-12-2020 | Tuberculosis | Case report

Hemophagocytic lymphohistiocytosis and miliary tuberculosis in a previously healthy individual: a case report

Authors: Linn Hereide Trovik, Miriam Sandnes, Bjørn Blomberg, Gunhild Holmaas, Aymen Bushra Ahmed, Tor Henrik Anderson Tvedt, Olav Vintermyr, Håkon Reikvam

Published in: Journal of Medical Case Reports | Issue 1/2020

Login to get access

Abstract

Background

Hemophagocytic lymphohistiocytosis (HLH) is a rare heterogenous genetic or acquired hyperinflammatory syndrome associated with a high degree of morbidity and mortality. HLH has clinical manifestations related to abnormal prolonged activation of T lymphocytes and macrophages with an excess of proinflammatory cytokines. The main causes of secondary HLH are malignancies and infectious diseases.

Case presentation

The patient was a 54-year-old man, originally from Eastern Africa, who had lived in Northern Europe for 30 years. Here we describe the clinical features, laboratory parameters, diagnostic workup, management and outcome data of a previously healthy 54-year-old man diagnosed with HLH secondary to tuberculosis. The patient was initially treated for a community-acquired pneumonia. He developed multiorgan failure with acute respiratory distress syndrome, hypertransaminasemia, and kidney and bone marrow dysfunction. The clinical course together with a simultaneous increase in serum ferritin raised the suspicion of HLH. The patient fulfilled seven out of eight diagnostic criteria for HLH. A thorough diagnostic workup with respect to HLH and a potential underlying disease was initiated. Cultivation of bronchoalveolar lavage fluid, stool and urine, and polymerase chain reaction of epithelioid cell granulomas in the bone marrow were all positive for Mycobacterium tuberculosis. He was treated for both HLH and tuberculosis, and he survived without any sequelae.

Conclusions

We present one of few published cases of a patient who survived HLH triggered by miliary tuberculosis. The current case illustrates the need for awareness of these two diagnoses, and the timely initiation of specific and supportive treatment to reduce mortality.
Literature
1.
go back to reference Allen CE, McClain KL. Pathophysiology and epidemiology of hemophagocytic lymphohistiocytosis. Hematol Am Soc Hematol Educ Program. 2015;2015:177–82.CrossRef Allen CE, McClain KL. Pathophysiology and epidemiology of hemophagocytic lymphohistiocytosis. Hematol Am Soc Hematol Educ Program. 2015;2015:177–82.CrossRef
2.
go back to reference Schram AM, Berliner N. How I treat hemophagocytic lymphohistiocytosis in the adult patient. Blood. 2015;125(19):2908–14.CrossRefPubMed Schram AM, Berliner N. How I treat hemophagocytic lymphohistiocytosis in the adult patient. Blood. 2015;125(19):2908–14.CrossRefPubMed
3.
4.
go back to reference Marsh RA, Haddad E. How I treat primary haemophagocytic lymphohistiocytosis. Br J Haematol. 2018;182(2):185–99.CrossRefPubMed Marsh RA, Haddad E. How I treat primary haemophagocytic lymphohistiocytosis. Br J Haematol. 2018;182(2):185–99.CrossRefPubMed
5.
go back to reference Lehmberg K, Ehl S. Diagnostic evaluation of patients with suspected haemophagocytic lymphohistiocytosis. Br J Haematol. 2013;160(3):275–87.CrossRefPubMed Lehmberg K, Ehl S. Diagnostic evaluation of patients with suspected haemophagocytic lymphohistiocytosis. Br J Haematol. 2013;160(3):275–87.CrossRefPubMed
6.
go back to reference Zhang K, Jordan MB, Marsh RA, Johnson JA, Kissell D, et al. Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH. Blood. 2011;118(22):5794–8.CrossRefPubMedPubMedCentral Zhang K, Jordan MB, Marsh RA, Johnson JA, Kissell D, et al. Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH. Blood. 2011;118(22):5794–8.CrossRefPubMedPubMedCentral
7.
go back to reference Risma KA, Marsh RA. Hemophagocytic lymphohistiocytosis: clinical presentations and diagnosis. J Allergy Clin Immunol Pract. 2019;7(3):824–32.CrossRefPubMed Risma KA, Marsh RA. Hemophagocytic lymphohistiocytosis: clinical presentations and diagnosis. J Allergy Clin Immunol Pract. 2019;7(3):824–32.CrossRefPubMed
8.
go back to reference Riviere S, Galicier L, Coppo P, Marzac C, Aumont C, et al. Reactive hemophagocytic syndrome in adults: a retrospective analysis of 162 patients. Am J Med. 2014;127(11):1118–25.CrossRefPubMed Riviere S, Galicier L, Coppo P, Marzac C, Aumont C, et al. Reactive hemophagocytic syndrome in adults: a retrospective analysis of 162 patients. Am J Med. 2014;127(11):1118–25.CrossRefPubMed
9.
go back to reference MacNeil A, Glaziou P, Sismanidis C, Maloney S, Floyd K. Global epidemiology of tuberculosis and progress toward achieving global targets—2017. MMWR Morb Mortal Wkly Rep. 2019;68(11):263–6.CrossRefPubMedPubMedCentral MacNeil A, Glaziou P, Sismanidis C, Maloney S, Floyd K. Global epidemiology of tuberculosis and progress toward achieving global targets—2017. MMWR Morb Mortal Wkly Rep. 2019;68(11):263–6.CrossRefPubMedPubMedCentral
10.
go back to reference Global tuberculosis report 2019. Geneva: World Health Organization; 2019. Licence: CC BY-NC-SA 3.0 IGO. Global tuberculosis report 2019. Geneva: World Health Organization; 2019. Licence: CC BY-NC-SA 3.0 IGO.
11.
go back to reference Brastianos PK, Swanson JW, Torbenson M, Sperati J, Karakousis PC. Tuberculosis-associated haemophagocytic syndrome. Lancet Infect Dis. 2006;6(7):447–54.CrossRefPubMed Brastianos PK, Swanson JW, Torbenson M, Sperati J, Karakousis PC. Tuberculosis-associated haemophagocytic syndrome. Lancet Infect Dis. 2006;6(7):447–54.CrossRefPubMed
12.
go back to reference Tseng YT, Sheng WH, Lin BH, Lin CW, Wang JT, et al. Causes, clinical symptoms, and outcomes of infectious diseases associated with hemophagocytic lymphohistiocytosis in Taiwanese adults. J Microbiol Immunol Infect. 2011;44(3):191–7.CrossRefPubMed Tseng YT, Sheng WH, Lin BH, Lin CW, Wang JT, et al. Causes, clinical symptoms, and outcomes of infectious diseases associated with hemophagocytic lymphohistiocytosis in Taiwanese adults. J Microbiol Immunol Infect. 2011;44(3):191–7.CrossRefPubMed
13.
go back to reference Riccardi N, Pontarelli A, Alagna R, Saderi L, Ferrarese M, et al. Epidemiology and treatment outcome of MDR and pre-XDR TB in international migrants at two reference centers in the North of Italy: a cross-sectional study coordinated by Stop TB Italia Onlus. Public Health. 2020;180:17–21.CrossRefPubMed Riccardi N, Pontarelli A, Alagna R, Saderi L, Ferrarese M, et al. Epidemiology and treatment outcome of MDR and pre-XDR TB in international migrants at two reference centers in the North of Italy: a cross-sectional study coordinated by Stop TB Italia Onlus. Public Health. 2020;180:17–21.CrossRefPubMed
14.
go back to reference Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124–31.CrossRefPubMed Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124–31.CrossRefPubMed
15.
go back to reference Blomberg B, Spinaci S, Fourie B, Laing R. The rationale for recommending fixed-dose combination tablets for treatment of tuberculosis. Bull World Health Organ. 2001;79(1):61–8.PubMedPubMedCentral Blomberg B, Spinaci S, Fourie B, Laing R. The rationale for recommending fixed-dose combination tablets for treatment of tuberculosis. Bull World Health Organ. 2001;79(1):61–8.PubMedPubMedCentral
16.
go back to reference La Rosee P, Horne A, Hines M, von Bahr GT, Machowicz R, et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 2019;133(23):2465–77.CrossRefPubMed La Rosee P, Horne A, Hines M, von Bahr GT, Machowicz R, et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 2019;133(23):2465–77.CrossRefPubMed
17.
go back to reference Stepp SE, Dufourcq-Lagelouse R, Le Deist F, Bhawan S, Certain S, et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science. 1999;286(5446):1957–9.CrossRefPubMed Stepp SE, Dufourcq-Lagelouse R, Le Deist F, Bhawan S, Certain S, et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science. 1999;286(5446):1957–9.CrossRefPubMed
18.
go back to reference Jenkins MR, Rudd-Schmidt JA, Lopez JA, Ramsbottom KM, Mannering SI, et al. Failed CTL/NK cell killing and cytokine hypersecretion are directly linked through prolonged synapse time. J Exp Med. 2015;212(3):307–17.CrossRefPubMedPubMedCentral Jenkins MR, Rudd-Schmidt JA, Lopez JA, Ramsbottom KM, Mannering SI, et al. Failed CTL/NK cell killing and cytokine hypersecretion are directly linked through prolonged synapse time. J Exp Med. 2015;212(3):307–17.CrossRefPubMedPubMedCentral
19.
go back to reference Janka GE, Lehmberg K. Hemophagocytic lymphohistiocytosis: pathogenesis and treatment. Hematol Am Soc Hematol Educ Program. 2013;2013:605–11.CrossRef Janka GE, Lehmberg K. Hemophagocytic lymphohistiocytosis: pathogenesis and treatment. Hematol Am Soc Hematol Educ Program. 2013;2013:605–11.CrossRef
20.
go back to reference Filipovich A, McClain K, Grom A. Histiocytic disorders: recent insights into pathophysiology and practical guidelines. Biol Blood Marrow Transplant. 2010;16(1 Suppl):S82–9.CrossRefPubMed Filipovich A, McClain K, Grom A. Histiocytic disorders: recent insights into pathophysiology and practical guidelines. Biol Blood Marrow Transplant. 2010;16(1 Suppl):S82–9.CrossRefPubMed
21.
go back to reference Yoon JH, Park SS, Jeon YW, Lee SE, Cho BS, et al. Treatment outcomes and prognostic factors in adult patients with secondary hemophagocytic lymphohistiocytosis not associated with malignancy. Haematologica. 2019;104(2):269–76.CrossRefPubMedPubMedCentral Yoon JH, Park SS, Jeon YW, Lee SE, Cho BS, et al. Treatment outcomes and prognostic factors in adult patients with secondary hemophagocytic lymphohistiocytosis not associated with malignancy. Haematologica. 2019;104(2):269–76.CrossRefPubMedPubMedCentral
22.
go back to reference Daver N, McClain K, Allen CE, Parikh SA, Otrock Z, et al. A consensus review on malignancy-associated hemophagocytic lymphohistiocytosis in adults. Cancer. 2017;123(17):3229–40.CrossRefPubMed Daver N, McClain K, Allen CE, Parikh SA, Otrock Z, et al. A consensus review on malignancy-associated hemophagocytic lymphohistiocytosis in adults. Cancer. 2017;123(17):3229–40.CrossRefPubMed
23.
go back to reference Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–4.CrossRefPubMedPubMedCentral Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–4.CrossRefPubMedPubMedCentral
24.
go back to reference Arranz Caso JA, Garcia Tena J, Llorens MM, Moreno R. High serum ferritin concentration in an AIDS patient with miliary tuberculosis. Clin Infect Dis. 1997;25(5):1263–4.CrossRefPubMed Arranz Caso JA, Garcia Tena J, Llorens MM, Moreno R. High serum ferritin concentration in an AIDS patient with miliary tuberculosis. Clin Infect Dis. 1997;25(5):1263–4.CrossRefPubMed
25.
go back to reference Weber SF, Belard S, Rai S, Reddy R, Belurkar S, et al. Immune thrombocytopenia secondary to tuberculosis: a case and review of literature. Int J Tuberc Lung Dis. 2017;21(4):466–70.CrossRefPubMed Weber SF, Belard S, Rai S, Reddy R, Belurkar S, et al. Immune thrombocytopenia secondary to tuberculosis: a case and review of literature. Int J Tuberc Lung Dis. 2017;21(4):466–70.CrossRefPubMed
26.
go back to reference Zhang Y, Liang G, Qin H, Li Y, Zeng X. Tuberculosis-associated hemophagocytic lymphohistiocytosis with initial presentation of fever of unknown origin in a general hospital: an analysis of 8 clinical cases. Medicine (Baltimore). 2017;96(16):e6575.CrossRef Zhang Y, Liang G, Qin H, Li Y, Zeng X. Tuberculosis-associated hemophagocytic lymphohistiocytosis with initial presentation of fever of unknown origin in a general hospital: an analysis of 8 clinical cases. Medicine (Baltimore). 2017;96(16):e6575.CrossRef
27.
go back to reference Kessler M, Reinig E. HLH associated with disseminated tuberculosis. N Engl J Med. 2020;382(18):1749.CrossRefPubMed Kessler M, Reinig E. HLH associated with disseminated tuberculosis. N Engl J Med. 2020;382(18):1749.CrossRefPubMed
28.
go back to reference Bergsten E, Horne A, Arico M, Astigarraga I, Egeler RM, et al. Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study. Blood. 2017;130(25):2728–38.CrossRefPubMedPubMedCentral Bergsten E, Horne A, Arico M, Astigarraga I, Egeler RM, et al. Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study. Blood. 2017;130(25):2728–38.CrossRefPubMedPubMedCentral
29.
go back to reference Johnson TS, Terrell CE, Millen SH, Katz JD, Hildeman DA, et al. Etoposide selectively ablates activated T cells to control the immunoregulatory disorder hemophagocytic lymphohistiocytosis. J Immunol. 2014;192(1):84–91.CrossRefPubMed Johnson TS, Terrell CE, Millen SH, Katz JD, Hildeman DA, et al. Etoposide selectively ablates activated T cells to control the immunoregulatory disorder hemophagocytic lymphohistiocytosis. J Immunol. 2014;192(1):84–91.CrossRefPubMed
30.
go back to reference Trottestam H, Horne A, Arico M, Egeler RM, Filipovich AH, et al. Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol. Blood. 2011;118(17):4577–84.CrossRefPubMedPubMedCentral Trottestam H, Horne A, Arico M, Egeler RM, Filipovich AH, et al. Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol. Blood. 2011;118(17):4577–84.CrossRefPubMedPubMedCentral
Metadata
Title
Hemophagocytic lymphohistiocytosis and miliary tuberculosis in a previously healthy individual: a case report
Authors
Linn Hereide Trovik
Miriam Sandnes
Bjørn Blomberg
Gunhild Holmaas
Aymen Bushra Ahmed
Tor Henrik Anderson Tvedt
Olav Vintermyr
Håkon Reikvam
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2020
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-020-02555-x

Other articles of this Issue 1/2020

Journal of Medical Case Reports 1/2020 Go to the issue